CarMax EVP and Chief Innovation and People Officer Diane Cafritz to depart Dec 31, 2026; enters consulting agreement

CARMAX INC

Diane Cafritz, EVP and Chief Innovation and People Officer, will leave CarMax effective December 31, 2026.
Severance modified: Cafritz receives 1.5x base salary plus full FY2027 actual bonus instead of 1.5x base+target bonus.
Consulting agreement from Jan 1 to June 30, 2027, pays $60,083.33/month ($360,500 total) for consulting services.
Non-compete and non-solicitation covenants extended by six months to 2.5 years from departure date.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Diane Cafritz

Executive Vice President and Chief Innovation and People Officer

KMX · CARMAX INC

Effective: 2026-12-31
Filed: July 31, 2026, 4:14 PM ET

On July 31, 2026, CarMax, Inc. (the “Company”) announced that Diane Cafritz, the Company’s Executive Vice President and Chief Innovation and People Officer, will be leaving the Company effective December 31, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Diane Cafritz departed as Executive Vice President and Chief Innovation and People Officer at CARMAX INC.

Action: leaving
Role: Executive Vice President and Chief Innovation and People Officer

Exact text from the filing

On July 31, 2026, CarMax, Inc. (the “Company”) announced that Diane Cafritz, the Company’s Executive Vice President and Chief Innovation and People Officer, will be leaving the Company effective December 31, 2026.

View on SEC.gov

CARMAX INC filing history →

Source: SEC EDGAR

accession 0001170010-26-000098

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.